Human umbilical cord mesenchymal stem cells improve disease characterization of Sjogren's syndrome in NOD mice through regulation of gut microbiota and Treg/Th17 cellular immunity.

MLA

Zou, Yao, et al. “Human Umbilical Cord Mesenchymal Stem Cells Improve Disease Characterization of Sjogren’s Syndrome in NOD Mice through Regulation of Gut Microbiota and Treg/Th17 Cellular Immunity.” Immunity, Inflammation & Disease, vol. 12, no. 1, Jan. 2024, pp. 1–12. EBSCOhost, https://doi.org/10.1002/iid3.1139.

APA

Zou, Y., Xiao, W., Liu, D., Li, X., Li, L., Peng, L., Xiong, Y., Gan, H., & Ren, X. (2024). Human umbilical cord mesenchymal stem cells improve disease characterization of Sjogren’s syndrome in NOD mice through regulation of gut microbiota and Treg/Th17 cellular immunity. Immunity, Inflammation & Disease, 12(1), 1–12. https://doi.org/10.1002/iid3.1139

Chicago

Zou, Yao, Wei Xiao, Dongzhou Liu, Xianyao Li, Lihua Li, Lijuan Peng, Ying Xiong, Haina Gan, and Xiang Ren. 2024. “Human Umbilical Cord Mesenchymal Stem Cells Improve Disease Characterization of Sjogren’s Syndrome in NOD Mice through Regulation of Gut Microbiota and Treg/Th17 Cellular Immunity.” Immunity, Inflammation & Disease 12 (1): 1–12. doi:10.1002/iid3.1139.